Literature DB >> 6432380

Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease.

H Ginsberg, G A Grabowski, J C Gibson, R Fagerstrom, J Goldblatt, H S Gilbert, R J Desnick.   

Abstract

Plasma lipid and serum apoprotein concentrations were determined in twenty-nine individuals with Gaucher type I disease. Plasma total cholesterol, low density lipoprotein (LDL) cholesterol and high density lipoprotein (HDL) cholesterol were all significantly reduced in the patients with Gaucher disease compared to a group of matched control subjects. Total, LDL and HDL cholesterol were lower in males than in females with Gaucher disease. These sex differences appeared to be inversely correlated with the severity of disease manifestations which were greater in the males. Serum levels of apoprotein-B and apoprotein-AI, the major structural apoproteins of LDL and HDL, respectively, were decreased in the subjects with Gaucher disease. Thus, the reductions in LDL and HDL cholesterol were associated with reduced numbers of lipoprotein particles in plasma. In contrast, apoprotein-E, a protein which is secreted by several tissues, including activated macrophages and which may mediate hepatic catabolism of lipoproteins, was elevated in the patients. Since macrophages may also catabolize lipoproteins, Gaucher disease may serve as a model for the effect of activated macrophages upon human lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432380     DOI: 10.1111/j.1399-0004.1984.tb00799.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study.

Authors:  Anca Zimmermann; Paula Grigorescu-Sido; Heidi Rossmann; Karl J Lackner; Cristina Drugan; Camelia Al Khzouz; Simona Bucerzan; Ioana Naşcu; Tim Zimmermann; Daniel Leucuţa; Matthias M Weber
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

2.  Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

Authors:  Hiroki Mizukami; Yide Mi; Ryuichi Wada; Mari Kono; Tadashi Yamashita; Yujing Liu; Norbert Werth; Roger Sandhoff; Konrad Sandhoff; Richard L Proia
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity.

Authors:  Philip Stein; Ruhua Yang; Jun Liu; Gregory M Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2011-02-03       Impact factor: 4.982

4.  Life expectancy in Gaucher disease type 1.

Authors:  Neal J Weinreb; Patrick Deegan; Katherine A Kacena; Pramod Mistry; Gregory M Pastores; Priscilla Velentgas; Stephan vom Dahl
Journal:  Am J Hematol       Date:  2008-12       Impact factor: 10.047

5.  High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease.

Authors:  Tamar H Taddei; James Dziura; Shu Chen; Ruhua Yang; Hideyuki Hyogo; Cameron Sullards; David E Cohen; Gregory Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-03-31       Impact factor: 4.982

6.  Serum lipid profile among sporadic and familial forms of Parkinson's disease.

Authors:  Daniel Macías-García; María Teresa Periñán; Laura Muñoz-Delgado; María Valle Jimenez-Jaraba; Miguel Ángel Labrador-Espinosa; Silvia Jesús; Dolores Buiza-Rueda; Carlota Méndez-Del Barrio; Astrid Adarmes-Gómez; Pilar Gómez-Garre; Pablo Mir
Journal:  NPJ Parkinsons Dis       Date:  2021-07-16

7.  An unusual case of massive hepatosplenomegaly.

Authors:  Amitabh Sagar; Abhishek Pathak; Vijay Bohra; Velu Nair
Journal:  Indian J Endocrinol Metab       Date:  2013-01

8.  PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia.

Authors:  Ivan H Chan; Dennis Van Hoof; Marina Abramova; Melissa Bilardello; Elliot Mar; Brett Jorgensen; Scott McCauley; Harminder Bal; Martin Oft; Peter Van Vlasselaer; John B Mumm
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

9.  Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.

Authors:  Avner Thaler; Shani Shenhar-Tsarfaty; Yanay Shaked; Tanya Gurevich; Nurit Omer; Anat Bar-Shira; Mali Gana-Weisz; Orly Goldstein; Meir Kestenbaum; Jesse M Cedarbaum; Avi Orr-Urtreger; Nir Giladi; Anat Mirelman
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

10.  Niemann-Pick disease type-B: a unique case report with compound heterozygosity and complicated lipid management.

Authors:  L Ordieres-Ortega; F Galeano-Valle; M Mallén-Pérez; C Muñoz-Delgado; J E Apaza-Chavez; F J Menárguez-Palanca; L A Alvarez-Sala Walther; P Demelo-Rodríguez
Journal:  BMC Med Genet       Date:  2020-05-06       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.